Tagged with clinic

Puerto Rico José F Rodríguez Orengo is the CEO and Chief Scientific Officer at the Fundación de Investigación (FDI) Clinical Trials, Puerto Rico’s main clinical research centre. In this interview, Rodríguez Orengo highlights his priorities of extending the capabilities and also becoming active in the space of public health. He also discusses…

Spain Through a merger between INC Research and inVentiv Health in 2018, Syneos Health has become the industry’s only fully integrated biopharmaceutical solutions organisation which includes one of the world’s top three global clinical research organisations (CRO) and a contract commercial organisation (CCO). Rosa Gonzalez Galindo explains the scale and scope…

France Nathalie Giraud, director of integrated monitoring investigator services & head of France at PPD, breaks down the strengths and weaknesses of the French clinical trials environment and stresses the importance of France in PPD’s overall operations. She also explains how the contract research organization is catering to the needs of…

Sweden The Karolinska University Hospital in Stockholm is one of the largest teaching hospitals in Europe and a globally renowned healthcare institution. Björn Zoëga was recently appointed as its director after major investments were made in a brand-new state-of-the-art facility. He explains the challenges that lie ahead, the hospital’s Patient First…

Sweden Dr Göran A. Ando, former chairman of Novo Nordisk and a Swedish life sciences industry veteran, recently moved back to his home country after over 35 years abroad. He shares his view on Swedish healthcare today, which is striving to continue its strong tradition of collaboration. Although Sweden is struggling…

Alzheimer's Alzheimer’s drugs represent a high-risk, high-reward proposition for global pharma. As David H. Crean recently wrote for PharmaBoardroom, “Except for one good piece of news in 2014 — for a dementia drug, Namzaric — there’s nothing by way of an FDA approval going back to 2002, 17 years of failure…

Taiwan Professor Ming-Shiang Wu, director of the Taiwan Clinical Trial Consortium, elaborates on the activities of the organization and its role to promote Taiwan’s clinical trial infrastructure and attract more international trials to the country. He also goes on to explain the key strengths of Taiwan within the Asia Pacific region.…

Sweden Over EUR 1 billion was spent in Sweden on pharmaceutical R&D in 2015, a similar level to spending seen in Italy and Denmark. Made with Visme Infographic Maker   Sweden is playing host to a growing number of clinical trials. The number of projects in clinical development in Sweden more…

Taiwan As part of its ‘Asia Silicon Valley Development Plan’, Taiwan has designated a special focus to each of its regions. The Taiwanese government is aiming to develop a new economic model and make Taiwan, “the stage for innovation talent in Asia and example of innovation and entrepreneurship, with the goal…

China Amidst the sea of Big Pharma executives jumping ship to start highly regarded and attention-grabbing biotech companies, bolstered by the huge influx of capital, the opening of stock exchanges in first Hong Kong and subsequently Shanghai to pre-profit biotech companies that meet certain criteria, as well as the reformation and…

USA Paul Bleicher, CEO at OptumLabs, and one of the speakers at the FT US Pharma & Biotech Summit on May 14, shares insights on the benefits we will see AI bring to pharma companies and patients in the short and long term, as well as use cases for the technology.…

Egypt Basyouni Abuseif, country president and CPO Head at Novartis Egypt, explains how the Swiss company has taken over the leadership position in the Egyptian pharmaceutical market despite economic and political challenges. He also highlights recent achievements of the government in fighting Hepatitis C, while emphasizing the need for more attention…